[Reflections about the impact caused by the Food and Drug Administration (FDA) warning against uterine and/or fibroid power morcellation]

Rev Bras Ginecol Obstet. 2015 Jul;37(7):299-301. doi: 10.1590/S0100-720320150005428.
[Article in Portuguese]
No abstract available

Publication types

  • Editorial

MeSH terms

  • Female
  • Humans
  • Leiomyoma / surgery*
  • Morcellation* / adverse effects
  • Neoplasm Seeding
  • United States
  • United States Food and Drug Administration*
  • Uterine Neoplasms / surgery*